BST/3FZ0 (BST/3FZ0)

Stuttgart Stock Exchange: BST/3FZ0 · EUR

€0.43

-0.01 (-3.4%)· Recorded snapshot

Market cap	6.6M
Revenue (ttm)	500.6K
Net income (ttm)	-2.7M
EPS (ttm)	-€0.43

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 500.6K
Net income (ttm): -2.7M
EPS (ttm): -€0.43
Market cap: 6.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.5P50 19.1P75 28.3

Trailing P/En/a

P25 14.1P50 23.7P75 38.5

ROE-115.1

P25 -50.4P50 0.5P75 12

ROIC-4.3

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

All BST/3FZ0 indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

NOK

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Norway
Country code	DE
Earnings date	2026-11-06
Employees	2
Employees change	-35
Employees growth	-94.57%
Enterprise value	EUR 13.2M
Exchange	Stuttgart Stock Exchange
Financial currency	NOK
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2000
Industry	Biotechnology
Is primary listing	No
ISIN number	NO0013735894
Last refreshed	2026-10-28
Last stock split date	2026-02-27
Last stock split type	Reverse
Market cap	EUR 6.6M
Next earnings date	2026-11-06
Price	EUR 0.43
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bst/3FZ0
Website	https://aquabiotechnology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-100.01%
EV/Sales	24.25x
FCF / EV yield	-4.64%
FCF yield	-9.32%
P/B ratio	1.8x
P/S ratio	13.14x
Price / tangible book value	1.8x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-83.84%
EBITDA margin	-152.19%
Gross margin	80.35%
Operating margin	-83.84%
Pretax margin	-497.8%
Profit per employee	EUR -1.4M
Revenue per employee	EUR 250,322
ROA	-1.84%
ROA (5Y)	-19.42%
ROCE	-4.16%
ROE	-115.14%
ROIC	-4.3%
SBC / revenue	0.99%
Tax / revenue	1.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth (Q)	-85.85%
Gross profit growth 3Y	-21.24%
Revenue growth	-30.73%
Revenue growth (Q)	-85.85%
Revenue growth (QoQ)	0%
Revenue growth 10Y	-18.87%
Revenue growth 3Y	-25.71%
Revenue growth 5Y	36.31%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	EUR -374,319
EBIT	EUR -419,759
EBITDA	EUR -761,938
EPS	EUR -0.43
Financing cash flow	EUR 679,747
Free cash flow	EUR -612,957
Free cash flow minus SBC	EUR -618,354
Gross profit	EUR 402,264
Income taxes	EUR 6,561
Net borrowing	EUR -313,791
Net cash flow	EUR 119,420
Net income	EUR -2.7M
Operating cash flow minus SBC	EUR -618,354
Operating income	EUR -419,759
Revenue	EUR 500,644
Stock-based compensation	EUR 4,934

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 0.24
Debt / equity	1.76
Interest coverage	-0.61
Long-term assets	EUR 10.3M
Long-term liabilities	EUR 6.4M
Net cash (debt)	EUR -6.1M
Net cash / market cap	-92.61%
Net debt / equity	1.66
Piotroski F-Score	2
Shareholders' equity	EUR 3.7M
Tangible book value	EUR 3.7M
Tangible book value per share	EUR 0.24
Total assets	EUR 10.8M
Total cash	EUR 344,879
Total debt	EUR 6.4M
Total liabilities	EUR 7.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.04
Current assets	EUR 493,271
Current liabilities	EUR 793,115
Current ratio	0.62
Net working capital	EUR -618,978
Quick ratio	0.62
Working capital	EUR -274,099
Working capital turnover	-0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-272.72%
Shareholder yield	-272.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 0.44
1D price change	-3.36%
1M price change	-4.21%
1M total return	-4.21%
1W price change	1.17%
1W total return	1.17%
1Y price change	-73.33%
1Y return CAGR	-73.36%
1Y total return	-73.33%
20-day SMA	EUR 0.43
200-day SMA	EUR 0.50
3Y price change	-96.56%
3Y return CAGR	-67.07%
3Y total return	-96.43%
50-day SMA	EUR 0.44
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 2.00
52-week high date	2025-12-29
52-week low	EUR 0.32
52-week low date	2026-08-05
5Y price change	-99.43%
5Y return CAGR	-64.17%
5Y total return	-99.41%
6M price change	-18.18%
6M total return	-18.18%
All-time high	EUR 87.25
All-time high date	2021-10-01
All-time low	EUR 0.32
All-time low date	2026-08-05
Average true range (ATR)	EUR 0.03
Average volume	0
Change from 52-week high	-78.4%
Change from 52-week low	35.85%
Change from all-time high	-99.5%
Change from all-time low	35.85%
Change from open	-2.26%
Day's gap	-1.12%
High price	EUR 0.45
Low price	EUR 0.43
Monthly RSI	28.97
Open price	EUR 0.44
Position in 52-week range	5.26%
Previous close	EUR 0.45
Price vs 150-day SMA	-2.22%
Price vs 20-day SMA	-0.55%
Price vs 200-day SMA	-14.05%
Price vs 50-day SMA	-2.61%
RSI	48.36
Sharpe ratio	-0.19
Sharpe ratio (3Y)	0.23
Sharpe ratio (5Y)	0.02
Sortino ratio	-0.25
Sortino ratio (3Y)	0.47
Sortino ratio (5Y)	0.09
Weekly RSI	39.94
YTD price change	-69.03%
YTD total return	-69.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.3M
Shares change (QoQ)	0%
Shares change (YoY)	272.72%
Shares held by insiders	15.17%

Deeper analysis on BST/3FZ0

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BST/3FZ0 report

Is a complete BST/3FZ0 research report available?

No complete published report is available for bst/3FZ0 (BST/3FZ0) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/3FZ0 (BST/3FZ0)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/3FZ0

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/3FZ0 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/3FZ0

Frequently asked questions